December 21, 2023
Now available AUGTYRO™
AUGTYRO™ (repotrectinib) is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).
Please see full prescribing information here.
Independence Day schedule
We will be closed on Friday, July 3 in observance of the Independence Day holiday. Delivery operations may vary across our network. We encourage you to review our full holiday schedule for more detailed information and to plan your orders accordingly.
We are NABP accredited
